Characteristics of Pharmacists’ Interventions Related to Proton-Pump Inhibitors in French Hospitals: An Observational Study

Author:

Yailian AL12,Huet E.3,Charpiat B.456,Conort O.67,Juste M.68,Roubille R.9,Bourdelin M.610,Gravoulet J.61112,Mongaret C.61314,Vermorel C.5,Bedouch P.5615,Janoly-Duménil A.126ORCID

Affiliation:

1. Pharmacy Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

2. Université Claude Bernard Lyon 1, Université de Lyon, UR 4129 Parcours Santé Systémique, Lyon, France

3. Pharmacy Department, Dieppe Hospital, Dieppe, France

4. Pharmacy Department, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon 69004, France

5. Université Grenoble Alpes, CNRS/TIMC UMR5525, F-38041, Grenoble, France

6. Working Group ‘Valorization of Pharmaceutical Interventions/Valorisation des Interventions Pharmaceutiques – Act-IP©’ of the French Society for Clinical Pharmacy, Marseille, France

7. Clinical Pharmacy Department, Cochin Hospital, APHP Centre, Cochin, Université de Paris, Paris, France

8. Pharmacy Department, Auban Mouet Hospital, Epernay, France

9. Pharmacy Department, Lucien Hussel Hospital, Vienne, France

10. Pharmacy Department, Nord-Ouest Villefrance Hospital, Villefranche sur Saône, France

11. Regional Union of Healthcare Professionals Pharmacists of the Grand Est (URPS), Nancy 54000, France

12. Lorraine University, Faculty of Pharmacy, Nancy 54000, France

13. Pharmacy Department, Reims University Hospital, Reims, France

14. Reims Champagne Ardennes, Faculty of Pharmacy, Reims, France

15. Pharmacy Department, Grenoble Alpes University Hospital, Grenoble 38043, France

Abstract

Background/Objective. Overprescribing proton-pump inhibitors (PPIs) has become the norm worldwide and represents a global health issue with tangible clinical and economic consequences. At national level, we do not know how pharmacists are contributing to this issue. Thus, the study focused on analyzing drug-related problems (DRPs) pertaining to PPI prescriptions, detected during the medication order review process in French hospitals, and associated pharmacist interventions (PIs). Methods. The study was based on a retrospective analysis of pharmacist interventions for DRPs detected during the medication order review and documented into the French Act-IP© database over a 12-year period. DRPs and PIs were analyzed, and independent factors of physician acceptance were assessed via multiple logistic regression. Results. Out of the 620,620 PIs registered, 29,694 targeted a PPI (4.8%). PPI’s DRPs were mostly related to the prescription of a “drug not available at the hospital” (26.1%) and a “drug use without indication” (18.3%); PIs were mostly “drug switch” (35.9%) and “drug discontinuation” (26.1%). In all, 18,919 PIs were accepted by physicians (63.7%). Acceptance was significantly associated with patient age: less accepted for the 18–75 years group (OR = 0.59, 95 CI [0.46–0.76]), and the >75 years group (OR = 0.57, 95 CI [0.44–0.73]) vs. <18 years group; for the type of DRP, “drug use without indication” was the less accepted (OR = 0.73, 95 CI [0.63–0.85]); for the type of PI, “dose adjustment” was the less accepted (OR = 0.32, 95 CI [0.23–0.45]). Conclusion. Pharmacists contribute to preventing DRPs associated with PPI prescriptions during the medication order review process. Moreover, they often detect PPIs used without indication and they propose drug discontinuation, which contributes to the PPI deprescribing process. PIs should be further developed in the future to reduce PPI overprescription.

Publisher

Hindawi Limited

Subject

General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3